organization · Reporting owner
SABBY MANAGEMENT, LLC
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Empery Digital Inc.
Report date October 15, 2024 · Filed October 17, 2024
Section 16 reporting ended · disclosed 2024-10-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 448,273 |
Reported balance
After 2024-10-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-10-15 · Other · Disposed 774,569 · Balance 448,273 F1: Sabby Volatility Warrant Master Fund, Ltd. (SVWMF) entered into a Securities Exchange Agreement with the Issuer pursuant to which SVWMF exchanged, on a 1:1 basis, 774,569 shares of the Issuer's Common Stock for an equal number of prefunded warrants, each to purchase one share of the Issuer's Common Stock at an exercise price of $0.00001 per share (each a "Pre-Funded Warrant"). F3: The amounts reported herein represent the entire amount of Issuer's common stock held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 (Section 16), beneficial ownership of such securities, except to the extent of its / his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F2: This Form 4 is being filed by SVWMF, Sabby Management, LLC (Advisor) and Hal Mintz. Advisor is investment manager to SVWMF. Mr. Mintz is manager of Advisor. |
| Prefunded Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee Footnotes | 774,569 |
Reported balance
After 2024-10-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-15 · Other · Acquired 774,569 · Balance 774,569 F4: The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants if it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. F1: Sabby Volatility Warrant Master Fund, Ltd. (SVWMF) entered into a Securities Exchange Agreement with the Issuer pursuant to which SVWMF exchanged, on a 1:1 basis, 774,569 shares of the Issuer's Common Stock for an equal number of prefunded warrants, each to purchase one share of the Issuer's Common Stock at an exercise price of $0.00001 per share (each a "Pre-Funded Warrant"). F2: This Form 4 is being filed by SVWMF, Sabby Management, LLC (Advisor) and Hal Mintz. Advisor is investment manager to SVWMF. Mr. Mintz is manager of Advisor. F3: The amounts reported herein represent the entire amount of Issuer's common stock held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 (Section 16), beneficial ownership of such securities, except to the extent of its / his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: Sabby Volatility Warrant Master Fund, Ltd. (SVWMF) entered into a Securities Exchange Agreement with the Issuer pursuant to which SVWMF exchanged, on a 1:1 basis, 774,569 shares of the Issuer's Common Stock for an equal number of prefunded warrants, each to purchase one share of the Issuer's Common Stock at an exercise price of $0.00001 per share (each a "Pre-Funded Warrant").
F2: This Form 4 is being filed by SVWMF, Sabby Management, LLC (Advisor) and Hal Mintz. Advisor is investment manager to SVWMF. Mr. Mintz is manager of Advisor.
F3: The amounts reported herein represent the entire amount of Issuer's common stock held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 (Section 16), beneficial ownership of such securities, except to the extent of its / his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.
F4: The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants if it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.
ReShape Weightloss Inc.
Report date January 31, 2019 · Filed February 04, 2019
Section 16 reporting ended · disclosed 2019-02-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 507 |
Last balance in matching sequence
After 2019-02-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2019-01-31 · Purchase · Acquired 10,301 · Balance 1,192,507 F1: This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor. F2: The amounts reported herein reflect the entire amount of the specified Issuer's security held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Row 2 · 2019-02-01 · Purchase · Disposed 1,192,000 · Balance 507 F3: On January 31, 2019, pursuant to Section 3(a)(9) of the Securities Act of 1933, SVWMF entered into an exchange agreement with the Issuer for the exchange of 1,192,000 shares of common stock for an equal number of shares of Series E Convertible Preferred Stock ("Preferred Stock"). Each share of Preferred Stock is convertible into one share of common stock at the election of SVWMF, provided that the Preferred Stock includes a provision which limits the holder's right to convert shares of Preferred Stock into common stock such that its beneficial ownership may not exceed 9.99% of the Issuer's outstanding common stock. F1: This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor. F2: The amounts reported herein reflect the entire amount of the specified Issuer's security held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
| Series E Convertible Preferred StockSEC Table II · derivative / convertible security · Expires 2039-02-01 | IndirectSee Footnotes | 1,192,000 |
Reported balance
After 2019-02-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-01 · Other · Acquired 1,192,000 · Balance 1,192,000 F3: On January 31, 2019, pursuant to Section 3(a)(9) of the Securities Act of 1933, SVWMF entered into an exchange agreement with the Issuer for the exchange of 1,192,000 shares of common stock for an equal number of shares of Series E Convertible Preferred Stock ("Preferred Stock"). Each share of Preferred Stock is convertible into one share of common stock at the election of SVWMF, provided that the Preferred Stock includes a provision which limits the holder's right to convert shares of Preferred Stock into common stock such that its beneficial ownership may not exceed 9.99% of the Issuer's outstanding common stock. F1: This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor. F2: The amounts reported herein reflect the entire amount of the specified Issuer's security held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor.
F2: The amounts reported herein reflect the entire amount of the specified Issuer's security held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.
F3: On January 31, 2019, pursuant to Section 3(a)(9) of the Securities Act of 1933, SVWMF entered into an exchange agreement with the Issuer for the exchange of 1,192,000 shares of common stock for an equal number of shares of Series E Convertible Preferred Stock ("Preferred Stock"). Each share of Preferred Stock is convertible into one share of common stock at the election of SVWMF, provided that the Preferred Stock includes a provision which limits the holder's right to convert shares of Preferred Stock into common stock such that its beneficial ownership may not exceed 9.99% of the Issuer's outstanding common stock.
Rosetta Genomics Ltd.
Report date October 17, 2018 · Filed April 22, 2019
Section 16 reporting ended · disclosed 2019-04-22. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2018 Filed Mar 16, 2018 10:28 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 200 | $0.42 | $84.00 |
DisclosureSEC source: 0001535610-18-000069 · primary_doc.xml · nonDerivative · entry 3 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 755,820 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 10:28 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 4,271 | $0.42 | $1,793.82 |
DisclosureSEC source: 0001535610-18-000069 · primary_doc.xml · nonDerivative · entry 2 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 755,620 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 10:28 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 800 | $0.42 | $335.92 |
DisclosureSEC source: 0001535610-18-000069 · primary_doc.xml · nonDerivative · entry 1 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 751,349 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 6,329 | $0.42 | $2,658.18 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 12 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 750,549 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 30,990 | $0.42 | $13,025.10 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 11 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 744,220 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 10 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 713,230 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 12,390 | $0.41 | $5,081.14 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 9 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 703,230 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 10,605 | $0.42 | $4,442.43 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 8 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 690,840 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 24,162 | $0.42 | $10,114.21 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 7 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 680,235 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 24,600 | $0.42 | $10,295.10 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 6 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 656,073 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 21,800 | $0.41 | $8,975.06 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 5 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 631,473 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 11,521 | $0.41 | $4,723.61 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 4 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 609,673 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 2,604 | $0.42 | $1,093.42 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 3 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 598,152 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 454 | $0.40 | $182.05 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 2 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 595,548 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 15:42 UTC | Rosetta Genomics Ltd. ROSG · Entity 158216 | PurchaseADR Shares (each one equal to 2 ordinary shares) | 20,373 | $0.42 | $8,554.62 |
DisclosureSEC source: 0001535610-18-000068 · primary_doc.xml · nonDerivative · entry 1 SABBY MANAGEMENT, LLC · CIK 0001535610 · 10% owner Sabby Healthcare Master Fund, Ltd. · CIK 0001561018 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 595,094 F1 · ownership.direct: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.direct: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. F1 · ownership.nature: This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor. F2 · ownership.nature: The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.